ATE57472T1 - Verfahren zum loesen von wirksubstanzen und auf diese weise erhaltene arzneimittel. - Google Patents

Verfahren zum loesen von wirksubstanzen und auf diese weise erhaltene arzneimittel.

Info

Publication number
ATE57472T1
ATE57472T1 AT85901459T AT85901459T ATE57472T1 AT E57472 T1 ATE57472 T1 AT E57472T1 AT 85901459 T AT85901459 T AT 85901459T AT 85901459 T AT85901459 T AT 85901459T AT E57472 T1 ATE57472 T1 AT E57472T1
Authority
AT
Austria
Prior art keywords
processes
way
active substances
dissolving active
drugs obtained
Prior art date
Application number
AT85901459T
Other languages
English (en)
Inventor
Jerome Corbiere
Original Assignee
Jerome Corbiere
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jerome Corbiere filed Critical Jerome Corbiere
Application granted granted Critical
Publication of ATE57472T1 publication Critical patent/ATE57472T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
AT85901459T 1984-03-14 1985-03-12 Verfahren zum loesen von wirksubstanzen und auf diese weise erhaltene arzneimittel. ATE57472T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH127984 1984-03-14
EP85901459A EP0173729B1 (de) 1984-03-14 1985-03-12 Verfahren zum lösen von wirksubstanzen und auf diese weise erhaltene arzneimittel
PCT/FR1985/000050 WO1985004106A1 (fr) 1984-03-14 1985-03-12 Ppocede de solubilisation de principes actifs et compositions pharmaceutiques ainsi obtenues

Publications (1)

Publication Number Publication Date
ATE57472T1 true ATE57472T1 (de) 1990-11-15

Family

ID=4206704

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85901459T ATE57472T1 (de) 1984-03-14 1985-03-12 Verfahren zum loesen von wirksubstanzen und auf diese weise erhaltene arzneimittel.

Country Status (12)

Country Link
US (1) US4794117A (de)
EP (1) EP0173729B1 (de)
JP (1) JPS61501566A (de)
KR (1) KR930000029B1 (de)
AT (1) ATE57472T1 (de)
AU (1) AU573321B2 (de)
DE (1) DE3580140D1 (de)
HU (1) HU195918B (de)
IT (1) IT1200410B (de)
NO (1) NO165626C (de)
OA (1) OA08170A (de)
WO (1) WO1985004106A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607662D0 (en) * 1986-03-27 1986-04-30 Rainsford K D Pharmaceutical formulation
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
DE3870111D1 (de) * 1987-09-11 1992-05-21 Syntex Inc Schutzmittel fuer augenzubereitungen.
US5110493A (en) * 1987-09-11 1992-05-05 Syntex (U.S.A.) Inc. Ophthalmic NSAID formulations containing a quaternary ammonium preservative and a nonionic surfactant
WO1991001718A1 (fr) * 1989-08-03 1991-02-21 Eisai Co., Ltd. Procede de photostabilisation pour collyre liquide et collyre liquide photostabilise
US5290774A (en) * 1989-08-03 1994-03-01 Eisai Co., Ltd. Photostabilizing method for ophthalmic solutions and the resulting ophthalmic solutions therefrom
DE4342907A1 (de) * 1993-12-16 1995-06-22 Bayer Ag Neue cyclische Depsipeptide mit 18 Ringatomen und ihre Verwendung zur Bekämpfung von Endoparasiten
BR9508655A (pt) * 1994-09-01 1997-08-12 Upjohn Co Composição farmacêutica aquosa estéril
US6274592B1 (en) * 1997-02-04 2001-08-14 Senju Pharmaceutical Co., Ltd. Method for stabilizing arylcarboxylic acid, stabilizer thereof and aqueous solution containing stabilized arylcarboxylic acid
US6844004B2 (en) * 1997-08-15 2005-01-18 Board Of Regents, The University Of Texas System Topical formulations of natamycin/pimaricin
US6045815A (en) * 1997-08-15 2000-04-04 Board Of Regents, The University Of Texas System Parenteral pimaricin as treatment of systemic infections
DE10030345A1 (de) * 2000-06-20 2002-01-10 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
US6387400B1 (en) 2000-08-29 2002-05-14 R.P. Scherer Technologies, Inc. Process for preparing pharmaceutical compositions for use with soft gelatin formulations
ITMI20012135A1 (it) 2001-10-16 2003-04-16 Bioren S A Soluzioni iniettabili pronte all'uso di paracetamolo
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) * 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
FR2851164B1 (fr) 2003-02-14 2005-04-22 Xuan Tho Nguyen Formulation liquide injectable de paracetamol
EP1568369A1 (de) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam zur Behandlung von Atemwegserkrankungen bei Schweinen
DE102004021281A1 (de) * 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
SG166115A1 (en) * 2005-09-30 2010-11-29 Boehringer Ingelheim Vetmed Pharmaceutical preparation containing meloxicam
US8497303B2 (en) * 2008-01-18 2013-07-30 Dow Global Technologies Llc Method to enhance aqueous solubility of poorly soluble actives
CN102300552A (zh) * 2009-02-03 2011-12-28 太阳星光齿磨公司 含有桔皮苷的组合物
AU2010307096B2 (en) * 2009-10-12 2014-07-03 Boehringer Ingelheim Vetmedica Gmbh Containers for compositions comprising meloxicam
US20110218191A1 (en) * 2010-03-03 2011-09-08 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long term-treatment of kidney disorders in cats
AU2010347598B2 (en) 2010-03-03 2014-11-27 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
KR20130094293A (ko) * 2010-07-21 2013-08-23 알콘 리서치, 리미티드 향상된 용해도 특성들을 갖는 약학 조성물
GB201321743D0 (en) * 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1916432A1 (de) * 1969-03-31 1970-10-08 Dresden Arzneimittel Verfahren zur Herstellung von Injektionsloesungen von therapeutisch wertvollen Benzodiazepinderivaten und ihren Kombinationen mit anderen Wirkstoffen
IL33774A0 (en) * 1970-01-26 1970-03-22 Abic Ltd A water-soluble composition comprising sulfadimidine and pyrimethamine
DK138974B (da) * 1974-02-19 1978-11-27 Ciba Geigy Ag Fremgangsmåde til fremstilling af vandige oxytetracyclinopløsninger til parenteral, peroral og lokal anvendelse.
DE3006024C2 (de) * 1980-02-18 1983-08-04 Solvon Arzneimittel-Vertriebs- Und Lizenzgesellschaft Mbh, 85011 Burgthann Topisches, Indomethacin enthaltendes Arzneimittel in Salbenform

Also Published As

Publication number Publication date
NO165626C (no) 1991-03-13
KR850700216A (ko) 1985-12-26
AU573321B2 (en) 1988-06-02
HU195918B (en) 1988-08-29
KR930000029B1 (ko) 1993-01-06
EP0173729A1 (de) 1986-03-12
DE3580140D1 (de) 1990-11-22
NO854461L (no) 1985-11-08
IT8519873A0 (it) 1985-03-13
JPS61501566A (ja) 1986-07-31
NO165626B (no) 1990-12-03
EP0173729B1 (de) 1990-10-17
US4794117A (en) 1988-12-27
AU4064585A (en) 1985-10-11
HUT38263A (en) 1986-05-28
IT1200410B (it) 1989-01-18
OA08170A (fr) 1987-03-31
WO1985004106A1 (fr) 1985-09-26

Similar Documents

Publication Publication Date Title
ATE57472T1 (de) Verfahren zum loesen von wirksubstanzen und auf diese weise erhaltene arzneimittel.
RU94027569A (ru) Органические соли n,n'-диацетилцистина, способ получения, фармацевтическая композиция, способы лечения
ATE87319T1 (de) Inklusionskomplexe von 7-isopropoxy-isoflavon mit cyclodextrinen, verfahren zu deren herstellung und diese inklusionskomplexe enthaltende pharmazeutische praeparate.
FI953467A0 (fi) Aminohappojohdannaisia, näitä yhdisteitä sisältävät lääkeaineet ja menetelmä niiden valmistamiseksi
ATE74519T1 (de) Waessrige loesung von fettloeslichen wirkstoffen.
DE68921760D1 (de) Behandlung von beschädigtem knochenmark und dosierungseinheiten dafür.
DK0580817T3 (da) Farmaceutisk præparat og fremgangsmåde til fremstilling deraf
FI942074A (fi) nor-sappijohdannaisia, menetelmä niiden valmistamiseksi ja näiden yhdisteiden käyttö lääkeaineina
YU69991A (sh) Derivati piridina
DE3789320T2 (de) Verabreichungsinstrument zum Einführen von festen Medikamenten.
PL301582A1 (en) Substituted derivatives 4-phenyl-pyridonyl and 4-phenyl-2-alkoxy pyridine, method of obtaining such derivative and therapeutical agents containing them
FR2618674B1 (fr) Microparticules comportant un polymere biodegradable controlant la liberation d'un principe actif antimalarique, compositions pharmaceutiques en comprenant et procede de preparation
DE69107493D1 (de) Arzneimittel zur transdermalen Verabreichung von Nitroglycerin.
NO180473C (no) Fremgangsmåte for fremstilling av et enteralt, farmasöytisk fôrpreparat for behandling av ektoparasittiske fiskesykdommer
IT1123503B (it) Derivati di acidi aziridin-2-carbossilici n-sostituiti con attivita'immunostimolante,processi per la loro preparazione e farmaci contenenti tali sostanze
IT7827078A0 (it) Derivati di acidi 2-idrazono propionici n-sostituti, processi per la loro preparazione e farmaci che contengono tali sostanze.
EP0271151A3 (de) Azumolen-Dosisformen
OA09794A (fr) Dérivés de pyridone amino acide azetidinyl substitués, leur préparation et leur application en tant que médicaments.
DK0538690T3 (da) Arylquinolyl-substituerede 1,4-dihydropyridin-dicarboxylsyrederivater, fremgangsmåde til deres fremstilling af deres anvendelse i lægemidler
FR2676648B1 (fr) Nouvelles compositions, leur procede de preparation et leurs applications comme substance active de medicament antigrippal ou antiviral.
PT81702A (de) N-substituierte aziridin-2-carbonsauerederivate verfahren zu deren herstellung sowie diese substanzen enthaltende arzneimittel
RU2014082C1 (ru) Противоопухолевое средство
RU95112241A (ru) Способ коррекции побочных эффектов химиолучевой терапии
TH6230A (th) สารผสมทางเภสัชกรรม
HU901875D0 (en) Process for production of galenical preparations providing optimal biological accessibility of 2-hydroxi-5-methyl-laurophenon-oxim as active substance